Watching risk: fairness, medical supervision, and the spectator problem in the enhanced games
Author:
Open Access
- 8 September 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Sports and Active Living
- Vol. 8, 1843832
Abstract
The Enhanced Games are often presented as an ethically improved alternative to conventional anti-doping sport because they replace prohibition with transparency, athlete autonomy, and medical supervision. The inaugural event, held in Las Vegas in May 2026, complicates rather than confirms this framing: several winners competed without enhancement, the substances used by others were often undisclosed, and only one world record was set. Open enhancement therefore does not straightforwardly resolve the ethical problems of fairness or harm; it reorganizes competition around access to biomedical optimization, tolerance of pharmacological risk, and physician-enabled performance escalation. This model also raises a neglected question: the ethics of the spectator. If audiences knowingly consume performances built on deliberate pharmacological risk, the moral problem is no longer confined to the athlete's consent; it extends to the collective normalization of medically hazardous enhancement as entertainment. The Enhanced Games should therefore be assessed not because they introduce risk into an otherwise safe world of sport, but because they institutionalize enhancement-related risk as a structural feature of competition and convert that risk into spectacle, with spectators as active, differentiated participants in that conversion.Keywords
This publication has 14 references indexed in Scilit:
- Enhanced Games: Bold claims, weak evidence, and serious risksBMJ, 2026
- Paying athletes can undermine their autonomySport, Ethics and Philosophy, 2026
- Bracketed morality and ethical ideologies of sport fansSport in Society, 2017
- The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysisAnnals of Epidemiology, 2014
- Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific StatementEndocrine Reviews, 2013
- Sports physicians, ethics and antidoping governance: between assistance and negligenceBritish Journal of Sports Medicine, 2013
- Should Performance-Enhancing Drugs in Sport be Legalized under Medical Supervision?Sports Medicine, 2011
- Sport, health and drugs: a critical re-examination of some key issues and problemsPerspectives in Public Health, 2009
- Why we should allow performance enhancing drugs in sportBritish Journal of Sports Medicine, 2004
- Sport medicine and the ethics of boxing.British Journal of Sports Medicine, 1999